Home Vulnerable groupNigeria’s TB Fight Faces Funding Crisis as Experts Call for Urgent Policy Action

Nigeria’s TB Fight Faces Funding Crisis as Experts Call for Urgent Policy Action

by Inclusive News Network

Nigeria’s battle against tuberculosis (TB) is facing a deepening funding and policy crisis, even as the disease continues to infect an estimated 1,200 to 1,300 people daily across the country. Health experts warn that without urgent domestic investment and decisive political will, Nigeria risks falling further behind global targets to end the epidemic.

Nigeria remains one of the world’s highest TB-burden countries, ranking first in Africa and among the top globally. An estimated 467,000 new TB cases occur annually. In 2024 alone, more than 400,000 cases were officially notified out of over 500,000 estimated infections, with treatment coverage at about 79 percent. Despite this progress, thousands of cases remain undetected, silently fueling transmission in homes, markets, schools, and rural communities where access to diagnosis is limited.

According to the World Health Organization, Nigeria faces a critical tuberculosis funding gap. Only about 18 percent of required TB funding is provided domestically, while roughly 73 percent of the national TB budget is expected to remain unfunded in 2025. This heavy dependence on external donors raises serious concerns about sustainability, especially as shifting global priorities threaten long-term support.

The funding shortfall has direct consequences for patients and communities. Limited resources slow the expansion of diagnostic services, weaken community case detection, and restrict outreach to underserved populations. In nearly half of Nigeria’s local government areas, advanced diagnostic tools such as GeneXpert machines are unavailable, leading to delayed diagnoses that allow the disease to spread and worsen before treatment begins.

Beyond financial constraints, stigma and misinformation continue to hinder Nigeria’s TB response. Fear and misconceptions discourage people from seeking testing and treatment, allowing undetected cases to persist. Health advocates note that a single untreated TB patient can infect several others each year, perpetuating the cycle of transmission and suffering.

Amid these challenges, the Leprosy and Tuberculosis Relief Initiative (LTR Nigeria) is emerging as a key driver of community-centered solutions. Through grassroots engagement, stigma-reduction campaigns, public awareness, and direct support to people affected by TB, the organization is helping bridge the gap between national policies and everyday realities. Its work underscores how replacing fear with knowledge and silence with support can significantly improve health outcomes.

Public health experts stress that while community initiatives are vital, they cannot replace strong national commitment. Ending TB in Nigeria is scientifically and medically achievable, as the disease is preventable, treatable, and curable. What remains, they argue, is a collective decision to prioritize TB within national budgets, strengthen health systems, expand access to diagnostics and treatment, and fully integrate TB care into universal health coverage.

As advocates emphasize, the fight against tuberculosis is not only a public health obligation but a moral imperative. With sustained funding, inclusive policies, and determined action—supported by organizations like LTR Nigeria—Nigeria has the capacity to turn the tide against TB and protect millions of lives.

Join Inclusive News Network WhatsApp Community For Quick Access To News and Happenings Around You.

Leave a Comment

* By using this form you agree with the storage and handling of your data by this website.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

You may also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Adblock Detected

Please support us by disabling your AdBlocker extension from your browsers for our website.